Organicell Regenerative Medicine, Inc. (OTCMKTS:BPSR – Get Free Report) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $2.17 and traded as low as $1.66. Organicell Regenerative Medicine shares last traded at $1.68, with a volume of 2,069 shares trading hands.
Organicell Regenerative Medicine Trading Down 2.3%
The business’s 50-day moving average price is $1.92 and its 200-day moving average price is $2.17.
Organicell Regenerative Medicine Company Profile
Organicell Regenerative Medicine, Inc is a clinical‐stage biotechnology company dedicated to the development and commercialization of cell and exosome‐based therapeutics for a variety of inflammatory and degenerative medical conditions. Leveraging its proprietary placental and amniotic tissue–derived platform, the company isolates and purifies extracellular vesicles (EVs) and mesenchymal‐like cells, which are studied for their ability to modulate immune response and promote tissue repair. With an emphasis on regenerative medicine, Organicell’s research efforts aim to translate novel biologics into scalable treatments.
The company’s pipeline is anchored by exosome‐centered product candidates that target pulmonary, ophthalmic, and musculoskeletal indications.
Read More
- Five stocks we like better than Organicell Regenerative Medicine
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Receive News & Ratings for Organicell Regenerative Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organicell Regenerative Medicine and related companies with MarketBeat.com's FREE daily email newsletter.
